FIELD: medicine.
SUBSTANCE: group of inventions refers to treatment or prevention of protozoal infection in a subject. That is ensured by using a compound or its pharmaceutically acceptable salt selected from: NCL015, NCL016, NCL017, NCL020, NCL021, NCL022, NCL023, NCL024, NCL025, NCL026, NCL027, NCL028, NCL029, NCL030, NCL031, NCL032, NCL033, NCL034, NCL035, NCL036, NCL037, NCL038, NCL039, NCL040, NCL041, NCL042, NCL043, NCL044, NCL045, NCL046, NCL052, NCL053, NCL054, NCL062, NCL072, NCL073, NCL074, NCL075, NCL076, NCL077, NCL078, NCL079, NCL080, NCL081, NCL082, NCL083, NCL084, NCL085, NCL086, NCL087, NCL088, NCL089, NCL093, NCL094, NCL096, NCL097, NCL099, NCL100, NCL101, NCL102, NCL103, NCL107, NCL108, NCL109, NCL110, NCL112, NCL113, NCL114, NCL115, NCL116, NCL117, NCL118, NCL119, NCL120, NCL121, NCL123, NCL125, NCL126, NCL127, NCL129, NCL130, NCL131, NCL132, NCL133, NCL134, NCL135, NCL136, NCL137, NCL138, NCL139, NCL140, NCL141, NCL143, NCL144, NCL145, NCL146, NCL147, NCL150, NCL151, NCL152, NCL153, NCL154, NCL155, NCL156, NCL160, NCL164, NCL165, NCL166, NCL170, NCL171, NCL172, NCL174, NCL175, NCL176, NCL177, NCL188, NCL190, NCL191, NCL215, NCL216, NCL217, NCL219, NCL224, NCL225, NCL226, NCL228, NCL229, NCL231, NCL232, NCL233, NCL234, NCL235, NCL236, NCL237, NCL248, NCL249, NCL254, NCL257, NCL259, NCL261, NCL263, NCL265, NCL266, NCL271, NCL272, NCL273, NCL274. Group of inventions relates to use of a compound or a pharmaceutically acceptable salt, to an antiprotozoal pharmaceutical composition containing a compound, as well as to a medical device containing the composition.
EFFECT: invention provides extending the range of products for treating or preventing protozoal infection in a subject.
19 cl, 13 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND METHODS OF TREATING INFECTIONS | 2014 |
|
RU2666540C2 |
| METHODS OF TREATING PROTOZOAL INFECTIONS | 2015 |
|
RU2818168C2 |
| COMPOUNDS AND METHODS FOR TREATMENT OF INFECTIONS | 2018 |
|
RU2779024C2 |
| DIAZACYCLOALKANES AS OXYTOCIN AGONISTS | 2002 |
|
RU2311417C2 |
| BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS | 2004 |
|
RU2340617C2 |
| OXYTOCIN ANTAGONISTS, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | 2002 |
|
RU2309156C2 |
| HETEROCYCLIC CONDENSED COMPOUNDS USEFUL AS ANTIDIURETIC AGENTS | 2005 |
|
RU2359969C2 |
| THIOPHENE DERIVATIVES | 2010 |
|
RU2536865C2 |
| BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
| COMPOSITIONS AND METHODS FOR TOPICAL PROSTAGLANDINS DELIVERY TO SUBCUTANEOUS FAT | 2014 |
|
RU2635864C2 |
